Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KLF9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAD54L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GHDC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAAP20 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GRK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FNDC3A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF519 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPATA24 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPHN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
P2RY8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GGCX - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TLE3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C12orf49 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MCEE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CNNM3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNASE4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on